NCT06723067 A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants
| NCT ID | NCT06723067 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas at Austin |
| Condition | Premature Birth |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-06-12 |
| Primary Completion | 2025-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-06-12 with a primary completion date of 2025-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A randomized controlled trial of impact of wearable, wireless breast pumps on how often and how much milk mothers of premature infants can pump.
Eligibility Criteria
Inclusion Criteria: * Mother of infant born at 29+6 weeks or below * Mother still pumping at 4 weeks since birth Exclusion Criteria: * Current use of mothers own wearable pump
Contact & Investigator
Alan Groves
PRINCIPAL INVESTIGATOR
University of Texas at Austin
Frequently Asked Questions
Who can join the NCT06723067 clinical trial?
This trial is open to female participants only, studying Premature Birth. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06723067 currently recruiting?
Yes, NCT06723067 is actively recruiting participants. Contact the research team at erica.ortiz@ascension.org for enrollment information.
Where is the NCT06723067 trial being conducted?
This trial is being conducted at Austin, United States.
Who is sponsoring the NCT06723067 clinical trial?
NCT06723067 is sponsored by University of Texas at Austin. The principal investigator is Alan Groves at University of Texas at Austin. The trial plans to enroll 30 participants.